ChromaDex (NASDAQ: CDXC) reported Q4 EPS of ($0.05), $0.04 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.6 million.

For earnings history and earnings-related data on ChromaDex (CDXC) click here.